A Reflection on 2023 – Key Takeaways
As we look toward a promising 2024, the ADVI Health team reflected on the biggest issues, regulations, and milestones that helped shape our healthcare landscape this year. From the Inflation Reduction Act (IRA) to a tremendous surge in growth and innovation, demand for data-informed insights, and increasingly more complex paths to market access, there is much to look back on from 2023.
We asked the ADVI team, “As you reflect on our critical work with clients across the healthcare landscape, what is the first key phrase or keyword that comes to mind?” Here’s what they shared.
Learn More
Stay ahead of the curve as you look toward 2024. Get in touch today to gain expert insights and strategic counsel on the evolving healthcare landscape.
CEO insights
Related articles
Real analysis from people who’ve been there
Medicare Negotiation Program Deselection: Analysis of Previously Deselected Drugs and Likely Fall 2026 Targets
Authored by Allison Schneider, MHA, and Lindsay Bealor Greenleaf, JD, MBA Under the Inflation Reduction Act, drugs selected for the …
Exclusive Webinar: Unpacking the Future of U.S. Drug Pricing Policy
Gain immediate access to actionable insights from CMS and ADVI Health policy leaders. From the Medicare Drug Price Negotiation Program …
Analysis of 340B modifier usage in Medicare Part B claims
Analysis of Part B Claims from January 2025 through June 2026 Prepared By:Johanna Celli, Pete Kardel, Caitlin Sheetz, ADVI Health’s …
The Growing Relevance of HEOR: Turning Complex Healthcare Questions Into Actionable Evidence
For the first time, ISPOR added “Relevance of HEOR: Demonstrating the Field’s Vital Role in Health” to its Top 10 …
CMS Proposes RAPID Coverage Pathway for Breakthrough Devices
IVDs remain outside scope, while FDA-CMS Parallel Review remains available. KEY TAKEAWAY RAPID could materially shorten the gap between Food …
ADVI Health Accelerates Insights with Monthly Medicare Data
ADVI Health now has access to 100% of Medicare Parts A, B, and D research files with monthly availability – …
Why Clinical Laboratories Should Consider Weighing In on CMS and CDC’s New CLIA Request for Information
An opportunity for laboratories to help shape the future of CLIA regulation On July 16, 2026, the Centers for Medicare …
RAND/UCLA Modified Delphi Panels
ADVI Health partners with pharmaceutical and biotech organizations to advance their evidence generation and market access strategies. We support complex research questions through primary research (e.g., …
Caitlin Sheetz, MPH
June 23, 2026
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.